PeptiMimesis Overview

  • Founded
  • 2015

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $323K

  • Investors
  • 2

PeptiMimesis General Information


Developer of transmembrane therapeutic peptides designed to identify peptidomimetic candidates suffering from hetero. The company develops its pipeline against key targets in the fields of oncology and immuno-oncology and is open to initiating collaboration with pharma partners on receptors of interest, enabling professionals to identify peptidomimetic candidates interfering with the hetero and/or the homodimerization of target receptors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 850 Boulevard Sébastien Brant
  • 67400 Illkirch
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PeptiMimesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 31-Mar-2020 $323K 00.000 00.000 Completed Generating Revenue
1. Seed Round 15-Mar-2017 00.000 00.000 00.000 Completed Generating Revenue
To view PeptiMimesis’s complete valuation and funding history, request access »

PeptiMimesis Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.00
A shares 7,143 $1.107247 $77.51 $77.51 1x $77.51 16.24%
To view PeptiMimesis’s complete cap table history, request access »

PeptiMimesis Executive Team (5)

Name Title Board Seat Contact Info
Marjorie Sidhoum Ph.D President
Gerard Cremel Co-Founder & Founding Member
Dominique Bagnard Ph.D Co-Founder
Pascal Neuville Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

PeptiMimesis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capital Grand Est PE/Buyout Minority 000 0000 000000 0
Domain Therapeutics VC-Backed Company Minority 000 0000 000000 0
To view PeptiMimesis’s complete investors history, request access »

PeptiMimesis Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 08-Jun-2020 00000 0000 Drug Discovery 00000000
To view PeptiMimesis’s complete investments history, request access »